Stories by Lauren J. Young

Creating artificial-intelligence models to find treatments for cardiac diseases

As millions of soccer fans pack FIFA World Cup venues, public health scientists created a wastewater monitoring network to forecast potential disease threats—from measles to Ebola

Dermatologists and skincare aficionados are excited for the U.S. to finally get a new, more protective sunscreen filter after more than 20 years of regulatory roadblocks. Here’s how bemotrizinol works

World Cup crowds spark outbreak tracking as AI tensions rise and ancient Rome’s roads get a stunning reboot

AI analysis of mammograms could provide a “bonus finding” for heart disease

People exposed to the Andes strain of the hantavirus may not develop symptoms for up to 42 days, a delay that makes tracing infections more difficult

Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare inherited eye diseases

A growing body of research suggests that GLP-1 drugs do more than control appetite and blood sugar. They could also fight inflammation

A sharp rise in U.S. measles cases is linked to falling MMR vaccination rates and growing immunity gaps

The Department of Health and Human Services and the Environmental Protection Agency announced a joint effort to track microplastics in drinking water—but experts say doing so will be difficult

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

Infectious disease experts say shots against meningococcal meningitis can be lifesaving during an outbreak, but U.S. regulators have attempted to roll back recommendations of such a vaccine for children

“Imitation” drugs, unexpected benefits, serious pitfalls—here’s what comes next as GLP-1 medications continue to rise in popularity

There’s no bulletproof remedy for a hangover, but a nutrition scientist explains which foods could aid symptoms after one has had too much to drink

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more effective when given at certain times of the day

Camp East Montana, one of the largest immigration detention facilities in the U.S., has reported 14 confirmed measles infections, triggering the El Paso center to close to visitors

A new study finds that heart attack deaths in U.S. hospitals are rising in people aged 54 and below, signaling a shift in cardiovascular issues in younger ages

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce drug- and alcohol-related overdoses and deaths

As the U.S. officially breaks 1,000 measles cases in 2026, experts say that the rate of infections is accelerating much faster this year than it did in years past

A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it

A new projection study estimates that nearly a third of women aged 20 to 44 will have been diagnosed with a cardiovascular disease by 2050

The FDA is reportedly considering broadening the types of drugs that can be sold without a prescription, a move some pharmacy experts say could raise safety risks

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications

A new study suggests that people with obesity have higher rates of mortality and hospitalization from a variety of infections from viruses, fungi, parasites and bacteria